1. Home
  2. CYTK vs GXO Comparison

CYTK vs GXO Comparison

Compare CYTK & GXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$77.91

Market Cap

7.6B

Sector

Health Care

ML Signal

HOLD

Logo GXO Logistics Inc.

GXO

GXO Logistics Inc.

HOLD

Current Price

$48.39

Market Cap

6.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYTK
GXO
Founded
1997
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Transportation Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.6B
6.6B
IPO Year
2004
2021

Fundamental Metrics

Financial Performance
Metric
CYTK
GXO
Price
$77.91
$48.39
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
19
11
Target Price
$89.26
$67.91
AVG Volume (30 Days)
1.5M
1.1M
Earning Date
05-05-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.28
Revenue
$13,368,000.00
$13,178,000,000.00
Revenue This Year
$7.37
$6.81
Revenue Next Year
$310.19
$5.95
P/E Ratio
N/A
$166.39
Revenue Growth
N/A
12.55
52 Week Low
$29.31
$37.97
52 Week High
$70.98
$66.85

Technical Indicators

Market Signals
Indicator
CYTK
GXO
Relative Strength Index (RSI) 75.97 35.54
Support Level $59.12 $45.84
Resistance Level N/A $54.88
Average True Range (ATR) 2.88 2.33
MACD 0.91 -0.98
Stochastic Oscillator 98.78 20.12

Price Performance

Historical Comparison
CYTK
GXO

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About GXO GXO Logistics Inc.

GXO Logistics Inc is a contract logistics company. Its revenue is diversified across numerous verticals and customers, including many multinational corporations. It provides warehousing and distribution, order fulfillment, e-commerce, reverse logistics, and other supply chain services differentiated by its ability to deliver technology-enabled, customized solutions at scale. Geographically, it generates revenue from the United Kingdom, the United States, the Netherlands, France, Spain, Italy, and other countries, and derives the majority of its revenue from the United Kingdom.

Share on Social Networks: